Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

"Did my cancer grow in 10 minutes?!": The limitations of CT scanning
Author
Howard (Jack) West, MD

A publication by Drs. Oxnard and colleagues from Memorial Sloan-Kettering Cancer Center just came out in the Journal of Clinical Oncology that should remind all of us of the pitfalls of taking very small changes in measurements too literally. As an exercise to test the variability in CT scanning, they had 30 eligible patients with stage III or IV lung cancer and a minimum tumor size of 1 cm undergo a CT scan, wait a few minutes, and then have a repeat CT scan within less than 15 minutes on the same scanner. Any of 3 expert radiologists read the scans and did tumor measurements, blinded to the timing of the scans. What they found was that 57% of the patients had a measurable difference in tumor size of a mm or more, and a third had a detected difference of 2 mm. The range of difference was as dramatic as a 23% shrinkage or 31% enlargement between the two scans, while 16% had a change of more than 10%, and 3% had a change significant enough within less than 15 minutes to be meet the criteria for disease progression by the formal criteria we use to assess response. Moreover, you could put these differences on a "waterfall plot" (with relative progression plotted as bars going up on the left side and relative shrinkage as bars going down on the right side of the curve) and it would produce a range of activity that would produce a fair amount of excitement that we'd found a new treatment that helps many of our patients: oxnard-waterfall-plot (click on image to enlarge)

Now, let's put aside the fanciful idea that the cancer has actually grown in less than 15 minutes, or that the effect of the radiation from a scan a few minutes ago led to tumor shrinkage measured on a repeat scan after a brief coffee break (or that the coffee shrank the tumor). Instead, what this should underscore is that tumor measurements aren't perfect. First, you can have slightly different appearance from one scan to the next because the slices of the scans can capture the nodule/mass at levels of slightly different thickness (imagine cutting 1-2 cm thick slices of a tennis ball: you might get different sizes depending on whether you catch the dead center of the ball or just on either side of it). More significantly, and likely far more commonly, you can get small differences based on the measurements of one radiologist vs. another or even the same radiologist reviewing a scan at two different times. There is a human element in the interpretation, which means that there is room for variability. This should also put the question of significance of differences of millimeters in measuring tumor progression into better perspective! I have long discussed the distinction between perceptible and clinically significant progression. Doctors and patients alike often over-react to incredibly minimal changes in CT scans, sometimes having people discontinue an otherwise very effective and well tolerated therapy because a new scan shows a millimeter or two of interval progression. We should bear in mind that you can see that level of variability just in redoing the scan a few minutes later or having it re-read by someone else, or perhaps the same radiologist after they have a cup of coffee. This is the same reason that many of the experts here suggest exercising caution in making broad interpretations of the significance of a slight bump in a serum tumor marker like CEA or an increase in the metabolic activity of a spot on a PET scan; these latter examples are less validated as ways to follow a cancer than a CT scan, and yet even here we see that our best and most objective criteria can fail us far more often than we'd suspect. So while this is humbling, the theme is to put observed changes in perspective of the bigger picture. A tiny change may just be noise in the system rather than a reason to reflexively jump to the next treatment.

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi Stan,

It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving.  I know it meant a...

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine that family and friends - our chosen family...

Recent Comments

JOIN THE CONVERSATION
Hey Bluebird,

I understand…
By JanineT GRACE … on
So good to hear from you Stan
By dbrock on
Hi Stan,

It's so good to…
By JanineT GRACE … on